Table 1.

Previously reported cases of hyperammonaemia syndrome secondary to Ureaplasma spp infection outside the lung transplant population

Case/(reference)	Year published	Age	Sex	Risk factor	Site of infection	Species	Diagnostic test	Treatment	Outcome
1/10	2020	16	F	Newly diagnosed acute myeloid leukaemia undergoing induction chemotherapy	Primary site not identified	U. parvum	PCR on blood	Doxycycline	Alive
2/11	2019	32	F	Acute lymphoblastic leukaemia undergoing salvage chemotherapy	Primary site not identified	U. urealyticum	PCR on blood	Levofloxacin	Died
3/12	2018	21	M	Post stem cell transplant for acute myeloid leukaemia	Pneumonia	U. parvum	PCR on tracheal aspirate	Azithromycin+levofloxacin	Alive
4/13	2021	53	F	Chimeric receptor antigen T-cell recipient for relapsed acute lymphoblastic leukaemia	Pneumonia	Not specified	PCR on BAL fluid	Levofloxacin	Died
5/14	2020	16	F	Kidney transplant	Joint (polyarthritis)	U. urealyticum	PCR on blood, urine, synovial fluid	Doxycycline+levofloxacin	Alive
6/15	2020	53	F	Liver-kidney transplant	Endovascular infection+Peritonitis	Not specified	PCR on intra-abdominal collections and stent	Doxycycline+levofloxacin	Alive
7/16	2020	56	F	Kidney transplant	Urinary tract	Not specified	16s on urine	Moxifloxacin+doxycycline	Alive
8/17	2020	65	F	Kidney transplant	Surgical site infection “chronic scar infection post kidney transplant”	U. parvum	PCR on blood and urine	Doxycycline+levofloxacin	Died

BAL, Bronchoalveolar lavage; F, female; M, male.